中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
20期
109-110,111
,共3页
吕晓芳%马瑞丽%方立峰%窦胜昔%郑权
呂曉芳%馬瑞麗%方立峰%竇勝昔%鄭權
려효방%마서려%방립봉%두성석%정권
胃黏膜脱垂%内镜下射频治疗%雷贝拉唑%铝镁加混悬液
胃黏膜脫垂%內鏡下射頻治療%雷貝拉唑%鋁鎂加混懸液
위점막탈수%내경하사빈치료%뢰패랍서%려미가혼현액
Gastric mucosa prolapse%Endoscopic radiofrequency ablation%Rabeprazole%Almagate suspension
目的:观察内镜下射频联合药物治疗胃黏膜脱垂疗效,为胃黏膜脱垂的治疗寻找有效方法。方法:对2009年1月-2012年 l2月经过胃镜、胃肠钡餐造影检查确诊为胃黏膜脱垂患者80例,随机分为观察组和对照组。观察组先采取内镜下对脱垂的胃黏膜进行射频点灼治疗,然后服用雷贝拉唑10 mg,每天2次,连续28 d,铝镁加混悬液15 ml,每天3次,连续28 d;对照组:不予射频治疗,服药与观察组相同。两组均于疗程结束后复查胃镜判断疗效。结果:观察组治愈率27.5%,显著高于对照组的7.5%(X2=5.77,P<0.05),观察组总有效率82.5%,显著高于对照组的55%(X2=7.04,P<0.05)。术后随访6个月,观察组1例复发(2.5%),对照组有8例复发(20%),两组差异有统计学意义(X2=4.51,P<0.05)。结论:内镜下射频联合雷贝拉唑、铝镁加混悬液疗效好,不良反应少,易于推广。
目的:觀察內鏡下射頻聯閤藥物治療胃黏膜脫垂療效,為胃黏膜脫垂的治療尋找有效方法。方法:對2009年1月-2012年 l2月經過胃鏡、胃腸鋇餐造影檢查確診為胃黏膜脫垂患者80例,隨機分為觀察組和對照組。觀察組先採取內鏡下對脫垂的胃黏膜進行射頻點灼治療,然後服用雷貝拉唑10 mg,每天2次,連續28 d,鋁鎂加混懸液15 ml,每天3次,連續28 d;對照組:不予射頻治療,服藥與觀察組相同。兩組均于療程結束後複查胃鏡判斷療效。結果:觀察組治愈率27.5%,顯著高于對照組的7.5%(X2=5.77,P<0.05),觀察組總有效率82.5%,顯著高于對照組的55%(X2=7.04,P<0.05)。術後隨訪6箇月,觀察組1例複髮(2.5%),對照組有8例複髮(20%),兩組差異有統計學意義(X2=4.51,P<0.05)。結論:內鏡下射頻聯閤雷貝拉唑、鋁鎂加混懸液療效好,不良反應少,易于推廣。
목적:관찰내경하사빈연합약물치료위점막탈수료효,위위점막탈수적치료심조유효방법。방법:대2009년1월-2012년 l2월경과위경、위장패찬조영검사학진위위점막탈수환자80례,수궤분위관찰조화대조조。관찰조선채취내경하대탈수적위점막진행사빈점작치료,연후복용뢰패랍서10 mg,매천2차,련속28 d,려미가혼현액15 ml,매천3차,련속28 d;대조조:불여사빈치료,복약여관찰조상동。량조균우료정결속후복사위경판단료효。결과:관찰조치유솔27.5%,현저고우대조조적7.5%(X2=5.77,P<0.05),관찰조총유효솔82.5%,현저고우대조조적55%(X2=7.04,P<0.05)。술후수방6개월,관찰조1례복발(2.5%),대조조유8례복발(20%),량조차이유통계학의의(X2=4.51,P<0.05)。결론:내경하사빈연합뢰패랍서、려미가혼현액료효호,불량반응소,역우추엄。
Objective:To observe endoscopic radiofrequency combined with drug therapy in gastric mucosa prolapse efficacy for the treatment of gastric mucosa prolapse to find effective methods. Method:Endoscopy,gastrointestinal barium meal diagnosed gastric mucosa prolapse of l2 months from January 2009 to 2012,after 80 patients were randomly divided into observation group and control group. The observation group was first taken Endoscopic gastric mucosa prolapse the RF point blanch treatment,and then taking rabeprazole 10 mg bid x 28 d Almagate suspension 15 ml tid×28 d;control group:no to radiofrequency treatment,medication and observation groups. In both groups after the end of treatment to determine the efficacy of endoscopy. Result:The observation group,the cure rate was 82.5%,significantly higher than that in the control group 55%,a significant difference( X2= 5.77, P<0.05)the observation group total effective rate of 82.5%,significantly higher than that in the control group 55%,a statistically difference( X 2= 7.04, P<0.05). 1(2.5%)patients relapsed patients were followed up for 6 months in the observation group,8 patients relapsed(20%)in the control group,the two groups of patients with a significant difference( X 2= 4.51,P<0.05). Conclusion:Endoscopic radiofrequency combined with rabeprazole Almagate suspension is effective,fewer adverse reactions,and easy to spread.